US5380411A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ultrasound or shock wave work process and preparation for carrying out same
Assignee: REINHARD SCHLIEF
•
Filing: 1988-12-02
•
Granted: 1995-01-10
•
Expires: 2008-12-02
Abstract
Abstract The invention relates to a shock wave or ultrasound work process wherein shock wave or ultrasound generators are used to produce shock waves or ultrasound in a medium in which an effect is to be achieved, wherein to this medium is added a preparation which contains or produces microbubbles which cause an intensification of the shock wave or ultrasound effect, and to a preparation for carrying out the process wherein this preparation can also be used for the specific destruction of biological tissue with ultrasound and shock waves.
Inventors
- 👤 Reinhard Schlief
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:29
CPC Classifications
A; A61; A61B; A61B8/00; A61B8/48; A61B8/481; A61K; A61K41/00; A61K49/00; A61K49/22; A61K49/222; A61K49/223; A61N; A61N7/00; A61P; A61P35/00
Claims Analysis
Total Claims: 33
Claim 1
Independent Claim
56 words
In a method for destroying tumor tissue, cells or other pathological tissue cells by means of shock waves or ultrasound, comprising subjecting said tissue or cells to shock waves or ultrasound field, wherein the improvement comprises that said tissue or cells are subjected to said shock waves or ultrasound in a preparation containing or producing microbubbles.
Claim 2
Dependent Claim
56 words
In a method for destroying tumor tissue, cells or other pathological tissue cells by means of shock waves or ultrasound, comprising subjecting said tissue or cells to shock waves or ultrasound field, wherein the improvement comprises that said tissue or cells are subjected to said shock waves or ultrasound in a preparation containing or producing microbubbles.
Claim 3
Dependent Claim
18 words
A method according to claim 1, wherein the shock waves or ultrasound field are focused on an area.
Claim 4
Dependent Claim
23 words
A method according to claim 2, wherein the shock waves or ultrasound field are radiated into the area by generators from different directions.
Claim 5
Dependent Claim
29 words
A method according to claim 1, wherein a generator of the shock waves or ultrasound field is swivelled about a focal point of said shock waves and ultrasound field.
Claim 6
Dependent Claim
28 words
A method according to claim 1, wherein the preparation is a suspension with microbubbles consisting essentially of microparticles of a boundary surface active substance in a fluid carrier.
Claim 7
Dependent Claim
77 words
A method according to claim 5, wherein the boundary surface active substance is a lecithin, polyoxyethylene fatty acid ester, glycerins polyethylene glycol ricinoleate, polyoxyethylene polyoxypropylene polymer, saccharose ester, xyloglyceride, saturated or unsaturated C 4-20 -fatty alcohol, saturated or unsaturated C 4-20 -fatty acid or a salt thereof, a mono- or di- or triglyceride, fatty acid ester, soya oil saccharose, glyceride or polyethylene glycol sorbitan monostearate as microparticles in a concentration of 0.001 to 10 percent by weight.
Claim 8
Dependent Claim
36 words
A method according to claim 5, wherein the boundary surface active substance is magnesium stearate, ascorbyl palmitate, saccharose monopalmitate, saccharose monostearate, saccharose distearate or butyl stearate in a concentration of 0.001 to 10 percent by weight.
Claim 9
Dependent Claim
39 words
A method according to claim 5, wherein the fluid carrier is physiologically compatible and is water, physiological electrolyte solution, an aqueous solution of single or multivalent alcohols or polyether alcohols or the aqueous solution of a mono- or disaccharide.
Claim 10
Dependent Claim
26 words
A method according to claim 5, wherein the fluid carrier is Ringer solution or Tyrode solution or an aqueous solution of maltose, dextrose, lactose or galactose.
Claim 11
Dependent Claim
23 words
A method according to claim 5, wherein the fluid carrier is an aqueous solution of glycerine, polyethylene glycol or propylene glycol methyl ether.
Claim 12
Dependent Claim
26 words
A method according to claim 5, wherein the preparation contains microparticles of a mixture of polyethylene glycol sorbitan monostearate and galactose in physiological sodium chloride solution.
Claim 13
Dependent Claim
24 words
A method according to claim 1, wherein the preparation is a suspension with microbubbles of a non-boundary surface active solid in a fluid carrier.
Claim 14
Dependent Claim
34 words
A method according to claim 12, wherein the non-boundary surface active solid is a cyclodextrin, monosaccharide, trisaccharide, polyol, or organic or inorganic salt thereof, with a concentration of 2 to 50 percent by weight.
Claim 15
Dependent Claim
15 words
A method according to claim 12, wherein the preparation contains microparticles of galactose in water.
Claim 16
Dependent Claim
21 words
A method according to claim 12, wherein the preparation contains microparticles of galactose in up to 20% by weight aqueous solution.
Claim 17
Dependent Claim
21 words
A method according to claim 12, wherein the preparation contains microparticles of lactose in up to 25% (by weight) aqueous solution.
Claim 18
Dependent Claim
39 words
A method according to claim 1, wherein the preparation is a suspension with microbubbles consisting essentially of microparticles of a mixture of at least one boundary surface active substance with a non-boundary surface active solid in a fluid carrier.
Claim 19
Dependent Claim
30 words
A method according to claim 12, wherein the non-boundary surface active solid is galactose, dextrose, maltose, lactose or a cyclodextrin in a concentration of 2 to 50 percent by weight.
Claim 20
Dependent Claim
21 words
A method according to claim 17, wherein the preparation contains microparticles of a mixture of butyl stearate and galactose in water.
Claim 21
Dependent Claim
24 words
A method according to claim 17, wherein the preparation contains microparticles of a mixture of oleic acid and galactose in physiological sodium chloride solution.
Claim 22
Dependent Claim
74 words
A method according to claim 1, wherein the preparation is a fluid solution with microbubbles consisting essentially of (a) a mixture of 0.1 to 10 percent by weight of a tenside or tenside mixture with an aqueous or water-miscible carrier fluid; and (b) a mixture of 0.5 to 50 percent by weight of a viscosity-enhancing substance or a substance mixture in an aqueous or water-miscible carrier fluid or a combination of (a) and (b).
Claim 23
Dependent Claim
85 words
A method according to claim 21, wherein the mixtures consist essentially of (a) 0.1 to 10 percent by weight of a tenside or tenside mixture in an aqueous or water-miscible carrier fluid which contains 0.05 to 5 percent by weight of a physiologically compatible carbonate; and (b) a mixture of 0.5 to 50 percent by weight of a viscosity-increasing substance or a substance mixture with an aqueous or water-miscible carrier fluid which contains the amount of physiologically compatible acid which is equivalent to the carbonate.
Claim 24
Dependent Claim
25 words
A method according to claim 21, wherein the preparation contains a non-ionogenic tenside which is a polyoxyethylene polyoxypropylene polymer which has a simultaneous viscosity-increasing effect.
Claim 25
Dependent Claim
32 words
A method according to claim 23, wherein the tenside consists essentially of polyoxyethylene polyoxypropylene polymers with the molecular weight 6800 to 8975 or which consists essentially of a polyoxyethylene fatty acid ester.
Claim 26
Dependent Claim
25 words
A method according to claim 21, wherein the preparation contains a tenside which consists essentially of polyoxyethylene stearates, sodium lauryl sulfate or sodium dioctyl sulfosuccinate.
Claim 27
Dependent Claim
29 words
A method according to claim 21, wherein the carrier fluid is water or a water-miscible single or multi-valent alcohol, physiological electrolyte solution an infusion solution or a mixture thereof.
Claim 28
Dependent Claim
55 words
A method according to claim 1, wherein the microbubbles have a coalescent resistant surface membrane in which there are a number of non-toxic and non-antigenic organic molecules and which contains a gas of a selected composition and wherein the diameter of the microbubbles is no greater than 300 micron and no smaller than 0,5 micron.
Claim 29
Dependent Claim
34 words
A method according to claim 27, wherein the molecules of the surface membrane have a hydrophilic and a hydrophobic section and their hydrophilic section is directed radially away from the center of a microbubble.
Claim 30
Dependent Claim
19 words
A method according to claim 27, wherein the surface membrane for the microbubbles consist essentially of a gellable composition.
Claim 31
Dependent Claim
12 words
A method according to claim 29, wherein the gellable composition is gelatin.
Claim 32
Dependent Claim
11 words
A method according to claim 1, wherein the preparation contains microparticles.
Claim 33
Dependent Claim
42 words
A method according to claim 1, wherein the size of the microbubbles and the frequency range of the ultrasound field are attuned with each other so that the resonance frequency of the microbubbles lies in the frequency range of the ultrasound field.
References Cited (Backward Citations)
US4276885A
Cited
US4681119A
Cited
US4466442A
Cited
CA1232837A
Cited
CA1239092A
Cited
US4920954A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-01-09 | 1998-07-11 | 1999-01-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-01-09 | 2002-07-11 | 2003-01-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-01-09 | 2006-07-11 | 2007-01-10 | $7700.00 | Window Closed / Lapsed |